Evaluation of delay in time to adjuvant chemotherapy after HIPEC and its impact on oncological outcome in advanced epithelial ovarian cancer

OBEJECTIVES: Optimal cytoreductive surgery (CRS), followed by adjuvant chemotherapy, is a major predictor of oncological outcome in patients with advanced epithelial ovarian carcinoma (EOC). It is not clear if a delayed start of adjuvant chemotherapy negatively impacts on the oncological outcome. ME...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pleura Peritoneum
Glavni autori: Somashekhar, S.P., Ramya, Y., Ashwin, K.R., Shabber, S.Z., Ahuja, V.K., Amit, R., Rohit, K.C.
Format: Artigo
Jezik:Inglês
Izdano: De Gruyter 2020
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7739892/
https://ncbi.nlm.nih.gov/pubmed/33364337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/pp-2020-0103
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items